Greetings

Welcome to the International Society of Liver Surgeons! I am Myron Schwartz, a liver surgeon at The Mount Sinai Hospital in New York, and I am excited to begin my two-year term as President of the Society. In the short eight years since its inception, the ISLS has grown to become the leading forum for liver transplant and hepatobiliary surgeons to share our experience as we advance our chosen field. While no one can deny the importance of multidisciplinary care in the management of patients with liver or biliary tract cancer, our focus is squarely on the craft of surgery. Our biannual Congress of Advanced HBP Surgery and our Single Topic Symposia and Consensus Conferences feature presentations on the latest developments in surgical technique and technology by the innovators who conceive them with animated discussion and debate among the acknowledged experts in the field, as well as open paper sessions where researchers from around the world can present their work.

Our Society promotes research aiming to advance the scientific basis of liver surgery through the formation of Study Groups led by surgeons who propose a research topic, design a protocol, enlist centers to participate, conduct the study, and present/publish the results. The Society has developed an online platform for data entry and provides study design and statistical support. The initial cadre of twelve groups has completed their projects, and the selection of studies for the next cycle is underway. The International Journal of Surgery (impact factor 15.3) has been designated as the official journal of the Society; abstracts presented at our Congress are published in a supplemental volume, and the papers produced by the Study Groups and by our Consensus Conferences will be submitted to the Journal for publication subject to peer review.

Education is a key aspect of our mission. The Society website is a treasure trove of educational material comprising webinars and videos as well as the complete proceedings of the Congresses, Consensus Conferences, and Single Topic Symposia, all accessible to the ISLS membership. We have also established a Fellowship in honor of the late pioneering surgeon Paolo Muiesan that enables an early-career surgeon to spend up to one year studying under the tutelage of a chosen mentor to accelerate the development of his/her technical and research capabilities.

As our Society evolves from a relatively informal gathering of friends and colleagues who share a common interest to a more formal organization that now boasts over 500 members from over 50 countries, we will do our best to maintain the spirit of friendship and collegiality that have distinguished us among the plethora of surgical societies that are out there. While our scope may broaden a bit to include nonsurgical alternatives and neoadjuvant/adjuvant therapies in order to provide context, and while there is some overlap with the technical aspects of pancreatic surgery, we shall remain a unique Society of Liver Surgeons at the cutting edge. I am honored and proud to serve you. I look forward to meeting you all at the next Congress of Advanced HBP Surgery in CANADA in October, 2025.

 

Myron SCHWARTZ, M.D

President, ISLS

Council

Myron SCHWARTZ, M.D

The Henry Kaufmann Professor of Surgery
Icahn School of Medicine at Mount Sinai, USA

President

Dieter BROERING, MD, PhD, FEBS, FACS

King Faisal Specialist Hospital & Research Center, Saudi Arabia

Vice-President

Maria B. Majella DOYLE, MD, MBA, FRCS

St. Louis Children's Hospital, USA

Vice-President

Ki-Hun KIM, M.D, Ph.D.

Asan Medical Center, University of Ulsan, Korea

Secretary General

Henrik PETROWSKY, M.D., FEBS, FACS

University Hospital Zürich, Switzerland

Treasurer

Deniz BALCI, M.D, Ph.D.

Bahçeşehir University School of Medicine, Türkiye

Chair, Scientific Committee

ISLS Member-at-Large

*Last Name Alphabetical Order

Fabrizio Di BENEDETTO

Modena University, Italy

Prashant BHANGUI

Medanta Institute, India

Marieke De BOER

University Medical Center Groningen, Netherlands

Albert CHAN

University of Hong Kong, Hong Kong

Alfred KOW Wei Chieh

National University of Singapore, Singapore

Ahmed ELSABBAGH

Gastroenterology Surgery and Liver Transplantation Center, Mansoura University, Egypt

Eduardo FERNANDES

Hospital Sao Lucas, Rio de Janeiro Federal University, Brazil

Karim HALAZUN

NYU Langone Health, USA

Dong-Sik KIM

Korea University Anam Hospital, Korea

Pal-Dag LINE

Oslo University Hospital, Norway

Lucas McCORMACK

Hospital Alemán, Argentina

Silvio NADALIN

University Hospital Tuebingen, Germany

Hugo PINTO MARQUES

Central Lisbon Hospital Centre, Portugal

Gonzalo SAPISOCHIN

Congress President, ISLS 2025

Toronto General Hospital, Canada

Olivier SCATTON

Pitié-Salpêtrière Hospital, France

Alejandro SERRABLO

Miguel Servet University Hospital, Spain

Shintaro YAGI

Kanazawa University, Japan

ISLS Study Group Board

*Last Name Alphabetical Order

Ruslan ALIKHANOV

MCSC-Moscow, Russia

Fabrizio Di BENEDETTO

Modena University, Italy

Prashant BHANGUI

Medanta Institute, India

Albert CHAN

Queen Mary Hospital, Hong Kong

Burcin EKSER

Indiana University, USA

Karim HALAZUN

NYU Langone Health, USA

Dong-jin JOO

Severance Hospital, Yonsei University, Korea

Dong Hwan JUNG

Asan Medical Center, University of Ulsan, Korea

Dong-Sik KIM

Korea University, Korea

Jong Man KIM

Samsung Medical Center, Sungkyunkwan University, Korea

Alfred KOW

National University of Singapore, Singapore

Pal-Dag LINE

University of Oslo, Norway

Massimo MALAGO

University College London, UK

Silvio NADALIN

Tubingen University, Germany

Henrik PETROWSKY

Zurich University, Switzerland

Cristiano QUINTINI

Cleveland Clinic, USA

Dimitri RAPTIS

Royal Free Hospital, London, UK

Fernando ROTELLAR

University of Navarra, Pamplona, Spain

Gonzalo SAPISOCHIN

University of Toronto, Canada

Parissa TABRIZIAN

MT. Sinai New York, USA

Orlando J. TORRES

Maranhão Federal University, Brazil

By-laws

These by-laws were approved at the Inaugural Council Meeting on March 18, 2024.

 

Endorsement

With the objective to disseminate scientific advances in surgery for hepatobiliary and pancreatic diseases and to provide continuing education related to the practice of liver surgery, the ISLS will grant its support to related societies by endorsing* meetings or events organized by such societies. Endorsements will be granted after reviewing the scientific programs, which must be submitted at the time of application.

Please read the guideline below and submit the application form if you wish to grant ISLS endorsement.

*ISLS endorsement does not include financial support or guarantees.